History and evolution

A lifetime of excellence, optimism and nonconformism

The beginnings date back to 1971 when a group of young entrepreneurs acquired a small laboratory in Madrid founded in 1954, called HIPRA (by the surnames of its former creators: Hidalgo and Prada), and moved to Amer (Girona).

^{HIPRA HQ in 1976}

The year 1991, with a workforce of 100 people and a turnover of 10 million euros, was a crucial year in HIPRA's history. A new highly motivated management team redefines the company's expansion policy. Thus begins an important period of technical and commercial expansion.

^{Products from the 90's era}

As of the year 2000, began the internationalization of HIPRA with the implementation of our own subsidiaries around the world. Currently HIPRA has commercial subsidiaries in 40 countries, 3 research centers and 6 production plants strategically located in Europe and America. Its extensive distribution network covers the 5 continents.

^{HIPRA Philippines, created in 2003, was one of the first HIPRA subsidiaries}

In 2009 the strategic positioning was refined with the clear mission of being the world leader in prevention, with differential and innovative products and, therefore, it stopped investing in pharmacological products.

^{The logo and claim where HIPRA's commitment to prevention is reflected}

In 2020, and in a context of the Covid-19 pandemic, a new challenge was faced using its extensive experience in innovative vaccines, the development of the vaccine against this new virus based on recombinant protein.

^{HIPRA expanded its facilities for human health}

In 2021 the new Human Health division was created to develop new innovative products. The same year GoodGut was acquired, a biotechnological start-up dedicated to the research and development of diagnostic tests for digestive diseases.

^{GoodGut facilities}